MKM Partners analyst Eric Handler maintains Hasbro (NASDAQ:HAS) with a Buy and lowers the price target from $118 to $105.
What 14 Analyst Ratings Have To Say About CRISPR Therapeutics
Within the last quarter, CRISPR Therapeutics (NASDAQ:CRSP) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…